STTK Shattuck Labs, Inc.

bullish · high conviction track record →
Get emailed when STTK changes direction
Mkt Cap $528M 52wk $0.71 - $8.33 4h ago
Insider buying: $11,237,365 bought by 9 insiders (30d)
Est. revisions: +1.5% (1 up, 0 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +1.4)

Factor Model

net +1.4
Est. Revisions
+0.1
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0

Cantor Fitzgerald starts STTK Overweight

Watch: Watch FDA trial readouts on DR3 and TL1A programs as catalysts for valuation re-rating.

Cantor Fitzgerald initiated coverage of Shattuck Labs with an Overweight rating on April 27, 2026. The stock jumped over 800% in the last 12 months, driven by enthusiasm for its DR3 and TL1A antibody programs. H.C. Wainwright raised the price target sharply from $6 to $18, reflecting higher success probabilities for SL-325 now at 15%. Multiple insiders, including Orbimed Advisors and Ashiya Mona, bought $5.47M of shares at $0.87, continuing a strong insider buying trend.

Strong insider buying and upgraded coverage indicate high conviction in the company's pipeline and growth potential, signaling confidence in future share price appreciation.

Evidence

4h ago Insider buy by REDMILE GROUP, L.L.C. (STTK): $166,714
4h ago Insider buy by SCHREIBER TAYLOR M.D., PH.D. (STTK): $44,220
4h ago Insider buy by BROUS TYLER (STTK): $32,768
4h ago Insider buy by SCHREIBER TAYLOR M.D., PH.D. (STTK): $50,011
4h ago Insider buy by ASHIYA MONA (STTK): $5,471,826
4h ago Insider buy by ORBIMED ADVISORS, L.L.C. (STTK): $5,471,826
Fundamentals & Data ▾
Shattuck Labs, Inc. Healthcare · Biotechnology
Mkt Cap
$528M
Beta
1.29
52w Range
$0.71 - $8.33
Short Interest
1.3M 1.85%
Days to Cover
2.4 -16%
Insiders
buying 6B / 1S
EPS Estimate
$-0.13 +1.5% 30d 1up / 0dn
Est. Dispersion
46% 5 analysts
Analyst Target
$12 $7 - $18
Insider Cluster
strong buy 5B / 1S (officer)
Fund Convergence
strong Renaissance, Two Sigma, Citadel
Top Holders
Renaissance $1M
Two Sigma
Citadel
Recent Filings & Data
insider trade 13
net buying · $166,714 sold · $11,237,365 bought
9 insiders · 13 transactions (30d)
Recent transactions
SCHREIBER TAYLOR M.D., PH.D. · award · $22,222
ORBIMED ADVISORS, L.L.C. · buy · $5,471,826
ASHIYA MONA · buy · $5,471,826
NEILL ANDREW R. · award · $55,556
SHUKLA ABHINAV A. PH.D. · award · $4,444
STOUT STEPHEN · award · $11,111
SIEGALL CLAY B · award · $111,112
REDMILE GROUP, L.L.C. · buy · $166,714
REDMILE GROUP, L.L.C. · sell · $166,714
SCHREIBER TAYLOR M.D., PH.D. · buy · $44,220
BROUS TYLER · buy · $32,768
SCHREIBER TAYLOR M.D., PH.D. · buy · $50,011
SCHREIBER TAYLOR M.D., PH.D. · exercise · $10,888
7 signals · latest 4h ago

Get alerted when STTK changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.